PA8549801A1 - Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales - Google Patents
Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animalesInfo
- Publication number
- PA8549801A1 PA8549801A1 PA20028549801A PA8549801A PA8549801A1 PA 8549801 A1 PA8549801 A1 PA 8549801A1 PA 20028549801 A PA20028549801 A PA 20028549801A PA 8549801 A PA8549801 A PA 8549801A PA 8549801 A1 PA8549801 A1 PA 8549801A1
- Authority
- PA
- Panama
- Prior art keywords
- mycoplasma bovis
- vaccine
- animals
- methods
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A VACUNAS DE MYCOPLASMA BOVIS Y A PROCEDIMIENTOS PARA EL TRATAMIENTO O PREVENCION DE UNA ENFERMEDAD O TRASTORNO EN UN ANIMAL CAUSADOS POR LA INFECCION CON MYCOPLASMA BOVIS, ADMINISTRANDO AL ANIMAL UNA CANTIDAD EFECTIVA DE UNA VACUNA DE MYCOPLASMA BOVIS. LA VACUNA DE MYCOPLASMA BOVIS PUEDE SER UNA PREPARACION DE CELULAS TOTALES O PARCIALES INACTIVADAS O VIVAS MODIFICADAS, UNA VACUNA DE SUBUNIDADES, O UNA VACUNA DE ACIDO NUCLEICO O ADN. LA VACUNA DE MYCOPLASMA BOVIS ADMINISTRADA DE ACUERDO CON LA PRESENTE SE PUEDE PRODUCIR POR SINTESIS O DE MANERA RECOMBINANTE. LA INVENCION TAMBIEN SE REFIERE A VACUNAS DE COMBINACION, PROCEDIMIENTOS PARA LA PREPARACION DE VACUNAS DE MYCOPLASMA BOVIS Y KITS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30263801P | 2001-07-02 | 2001-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8549801A1 true PA8549801A1 (es) | 2003-09-17 |
Family
ID=23168600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20028549801A PA8549801A1 (es) | 2001-07-02 | 2002-07-02 | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030147914A1 (es) |
| EP (1) | EP1401488A1 (es) |
| JP (1) | JP2004536106A (es) |
| KR (1) | KR20040030783A (es) |
| CN (1) | CN1522152A (es) |
| AP (1) | AP2002002568A0 (es) |
| AR (1) | AR036125A1 (es) |
| BG (1) | BG108496A (es) |
| BR (1) | BR0210798A (es) |
| CA (1) | CA2452580A1 (es) |
| CZ (1) | CZ20033465A3 (es) |
| EA (1) | EA200301324A1 (es) |
| GT (1) | GT200200139A (es) |
| HN (1) | HN2002000162A (es) |
| HR (1) | HRP20031078A2 (es) |
| HU (1) | HUP0501188A2 (es) |
| IL (1) | IL159516A0 (es) |
| IS (1) | IS7078A (es) |
| MA (1) | MA27048A1 (es) |
| MX (1) | MXPA03011815A (es) |
| NO (1) | NO20035767L (es) |
| OA (1) | OA12640A (es) |
| PA (1) | PA8549801A1 (es) |
| PE (1) | PE20030239A1 (es) |
| PL (1) | PL373891A1 (es) |
| SK (1) | SK15802003A3 (es) |
| TN (1) | TNSN03154A1 (es) |
| UY (1) | UY27365A1 (es) |
| WO (1) | WO2003004052A1 (es) |
| YU (1) | YU102103A (es) |
| ZA (1) | ZA200309747B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| UY29915A1 (es) * | 2005-11-15 | 2007-06-29 | Boehringer Ingelheim Vetmed | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina |
| EP2121721A4 (en) * | 2006-09-07 | 2010-10-06 | Boehringer Ingelheim Vetmed | GENOTYPING BASED ON PCR |
| RS54981B1 (sr) | 2006-09-11 | 2016-11-30 | Zoetis P Llc | Bakterini tretirani toplotom i vakcine tipa emulzije izrađene od ovakvih bakterina tretiranih toplotom |
| AR069087A1 (es) * | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| AU2009265092B2 (en) * | 2008-07-03 | 2015-09-03 | Biotechnology Research And Development Corporation | Cattle vaccines |
| AU2009309041B2 (en) * | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| CA2764424C (en) | 2009-06-04 | 2019-12-31 | National Institute Of Advanced Industrial Science And Technology | Vaccine for mycoplasma infection |
| CN102220263B (zh) * | 2011-05-06 | 2012-10-03 | 华中农业大学 | 一种牛支原体致弱菌株及其应用 |
| CN104968365B (zh) | 2012-12-28 | 2018-04-03 | 勃林格殷格翰动物保健有限公司 | 支原体疫苗的制备方法 |
| CN104857509A (zh) * | 2015-06-02 | 2015-08-26 | 福清市默克兽医院 | 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法 |
| PL3334454T3 (pl) | 2015-08-14 | 2023-01-30 | Zoetis Services Llc | Kompozycje mycoplasma bovis |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN106929452B (zh) * | 2017-04-11 | 2020-06-12 | 河南省农业科学院畜牧兽医研究所 | 一株牛支原体及其应用 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN112301041B (zh) * | 2020-10-09 | 2022-05-24 | 华中农业大学 | 牛支原体p21蛋白及其应用 |
| CN113546162B (zh) * | 2021-05-31 | 2023-07-18 | 江苏省农业科学院 | 一种支原体疫苗及其制备方法 |
| CN113604492B (zh) * | 2021-09-10 | 2023-07-07 | 苏州世诺生物技术有限公司 | 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| WO2001034189A2 (en) * | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Felgentraeger & Co Oeko Chem U | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2002
- 2002-06-20 US US10/177,857 patent/US20030147914A1/en not_active Abandoned
- 2002-06-27 IL IL15951602A patent/IL159516A0/xx unknown
- 2002-06-27 JP JP2003510062A patent/JP2004536106A/ja active Pending
- 2002-06-27 BR BRPI0210798-8A patent/BR0210798A/pt not_active IP Right Cessation
- 2002-06-27 AP APAP/P/2002/002568A patent/AP2002002568A0/en unknown
- 2002-06-27 CN CNA028132882A patent/CN1522152A/zh active Pending
- 2002-06-27 TN TNPCT/IB2002/002514A patent/TNSN03154A1/fr unknown
- 2002-06-27 KR KR10-2004-7000003A patent/KR20040030783A/ko not_active Application Discontinuation
- 2002-06-27 EP EP02738544A patent/EP1401488A1/en not_active Withdrawn
- 2002-06-27 PL PL02373891A patent/PL373891A1/xx unknown
- 2002-06-27 MX MXPA03011815A patent/MXPA03011815A/es unknown
- 2002-06-27 EA EA200301324A patent/EA200301324A1/ru unknown
- 2002-06-27 YU YU102103A patent/YU102103A/sh unknown
- 2002-06-27 CA CA002452580A patent/CA2452580A1/en not_active Abandoned
- 2002-06-27 CZ CZ20033465A patent/CZ20033465A3/cs unknown
- 2002-06-27 SK SK1580-2003A patent/SK15802003A3/sk not_active Application Discontinuation
- 2002-06-27 OA OA1200300346A patent/OA12640A/en unknown
- 2002-06-27 WO PCT/IB2002/002514 patent/WO2003004052A1/en not_active Application Discontinuation
- 2002-06-27 HU HU0501188A patent/HUP0501188A2/hu unknown
- 2002-06-28 HN HN2002000162A patent/HN2002000162A/es unknown
- 2002-07-01 UY UY27365A patent/UY27365A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000592A patent/PE20030239A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102480A patent/AR036125A1/es unknown
- 2002-07-02 PA PA20028549801A patent/PA8549801A1/es unknown
- 2002-07-02 GT GT200200139A patent/GT200200139A/es unknown
-
2003
- 2003-12-15 IS IS7078A patent/IS7078A/is unknown
- 2003-12-17 ZA ZA200309747A patent/ZA200309747B/xx unknown
- 2003-12-22 NO NO20035767A patent/NO20035767L/no not_active Application Discontinuation
- 2003-12-22 BG BG108496A patent/BG108496A/xx unknown
- 2003-12-23 HR HR20031078A patent/HRP20031078A2/hr not_active Application Discontinuation
- 2003-12-31 MA MA27469A patent/MA27048A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR036125A1 (es) | 2004-08-11 |
| MXPA03011815A (es) | 2004-04-02 |
| UY27365A1 (es) | 2003-04-30 |
| WO2003004052A1 (en) | 2003-01-16 |
| BR0210798A (pt) | 2006-05-23 |
| HUP0501188A2 (en) | 2006-05-29 |
| CN1522152A (zh) | 2004-08-18 |
| HN2002000162A (es) | 2002-09-17 |
| YU102103A (sh) | 2006-05-25 |
| PE20030239A1 (es) | 2003-03-21 |
| ZA200309747B (en) | 2005-05-27 |
| PL373891A1 (en) | 2005-09-19 |
| AP2002002568A0 (en) | 2002-06-30 |
| KR20040030783A (ko) | 2004-04-09 |
| JP2004536106A (ja) | 2004-12-02 |
| IL159516A0 (en) | 2004-06-01 |
| US20030147914A1 (en) | 2003-08-07 |
| BG108496A (en) | 2005-02-28 |
| NO20035767L (no) | 2004-01-30 |
| OA12640A (en) | 2006-06-15 |
| TNSN03154A1 (fr) | 2005-12-23 |
| SK15802003A3 (sk) | 2005-01-03 |
| HRP20031078A2 (en) | 2005-08-31 |
| EA200301324A1 (ru) | 2004-12-30 |
| GT200200139A (es) | 2003-02-13 |
| IS7078A (is) | 2003-12-15 |
| MA27048A1 (fr) | 2004-12-20 |
| EP1401488A1 (en) | 2004-03-31 |
| CA2452580A1 (en) | 2003-01-16 |
| CZ20033465A3 (cs) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8549801A1 (es) | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales | |
| PA8549701A1 (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
| AR034677A1 (es) | Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado | |
| MX2020010941A (es) | Moleculas y composiciones novedosas de arn de vsr para vacunacion. | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
| BR112022016507A2 (pt) | Vacinas contra o coronavírus e métodos de uso | |
| AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
| AR036355A1 (es) | Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas | |
| UY26763A1 (es) | Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo. | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| ATE442857T1 (de) | Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird) | |
| DE602005011041D1 (de) | Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort | |
| Fisman et al. | Have you herd? Indirect flu vaccine effects are critically important | |
| ATE515270T1 (de) | Phep, eine aminosäurepermease von staphylococcus aureus | |
| JP5865839B2 (ja) | 粘膜アジュバント組成物 | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| RU2539105C1 (ru) | Препарат для лечения некробактериоза крупного рогатого скота | |
| MX2023005154A (es) | Nanopartículas codificadas de adn y método de uso de las mismas como una vacuna contra la enfermedad corona virus (covid-19). | |
| ES2172482B1 (es) | Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania". | |
| CY1116862T1 (el) | Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae | |
| El-Bagoury et al. | Comparative evaluation of different inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 61 VG, montanide oil ISA 201 VG, and aluminum hydroxide gel | |
| El-Bagoury et al. | Evaluation of inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 201 VG | |
| UA57410A (uk) | Спосіб виготовлення вакцини інактивованої проти набрякової хвороби (коліентеротоксемії) поросят | |
| UA12940U (en) | Associated inactivated concentrated velshipast vaccine against anaerobic enterotoxicemia and pasteurellosis of animals |